Application of advanced MRI techniques to monitor pharmacologic and rehabilitative treatment in multiple sclerosis: current status and future perspectives

被引:20
|
作者
Rocca, Maria A. [1 ,2 ]
Preziosa, Paolo [1 ]
Filippi, Massimo [1 ,2 ]
机构
[1] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Div Neurosci, Neuroimaging Res Unit,Inst Expt Neurol, Milan, Italy
[2] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Div Neurosci, Dept Neurol,Inst Expt Neurol, Milan, Italy
关键词
Disease modifying treatments; magnetic resonance imaging; multiple sclerosis; rehabilitation; treatment monitoring; MAGNETIZATION-TRANSFER RATIO; PLACEBO-CONTROLLED TRIAL; SUBCUTANEOUS INTERFERON BETA-1A; BRAIN VOLUME LOSS; STEM-CELL TRANSPLANTATION; WHITE-MATTER PATHOLOGY; SPINAL-CORD VOLUME; HIGH-YIELD PROCESS; GLATIRAMER ACETATE; DOUBLE-BLIND;
D O I
10.1080/14737175.2019.1555038
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Advances in magnetic resonance imaging (MRI) technology and analyses are improving our understanding of the pathophysiology of multiple sclerosis (MS). Due to their ability to grade the presence of irreversible tissue loss, microstructural tissue abnormalities, metabolic changes and functional plasticity, the application of these techniques is also expanding our knowledge on the efficacy and mechanisms of action of different pharmacological and rehabilitative treatments. Areas covered: This review discusses recent findings derived from the application of advanced MRI techniques to evaluate the structural and functional substrates underlying the effects of pharmacologic and rehabilitative treatments in patients with MS. Current applications as outcome in clinical trials and observational studies, their interpretation and possible pitfalls in their use are discussed. Finally, how these techniques could evolve in the future to improve monitoring of disease progression and treatment response is examined. Expert commentary: The number of treatments currently available for MS is increasing. The application of advanced MRI techniques is providing reliable and specific measures to better understand the targets of different treatments, including neuroprotection, tissue repair, and brain plasticity. This is a fundamental progress to move toward personalized medicine and individual treatment selection.
引用
收藏
页码:835 / 866
页数:32
相关论文
共 50 条
  • [41] Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
    Hsu, Chih-Hung
    Shen, Ying-Chun
    Shao, Yu-Yun
    Hsu, Chiun
    Cheng, Ann-Lii
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2014, 1 : 85 - 99
  • [42] Tazemetostat for advanced epithelioid sarcoma: current status and future perspectives
    Simeone, Noemi
    Frezza, Anna Maria
    Zaffaroni, Nadia
    Stacchiotti, Silvia
    FUTURE ONCOLOGY, 2021, 17 (10) : 1253 - 1263
  • [43] A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
    D'Amico, Emanuele
    Patti, Francesco
    Zanghi, Aurora
    Zappia, Mario
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (10)
  • [44] Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
    Yuri Matteo Falzone
    Tommaso Russo
    Teuta Domi
    Laura Pozzi
    Angelo Quattrini
    Massimo Filippi
    Nilo Riva
    NeuralRegenerationResearch, 2021, 16 (10) : 1985 - 1991
  • [45] Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
    Falzone, Yuri Matteo
    Russo, Tommaso
    Domi, Teuta
    Pozzi, Laura
    Quattrini, Angelo
    Filippi, Massimo
    Riva, Nilo
    NEURAL REGENERATION RESEARCH, 2021, 16 (10) : 1985 - 1991
  • [46] The Treatment of Bipolar Depression: Current Status and Future Perspectives
    Luke A. Jelen
    Allan H. Young
    Current Behavioral Neuroscience Reports, 2020, 7 : 1 - 14
  • [47] Current status and future perspectives on the medical treatment of neurocysticercosis
    Gonzales, Isidro
    Garcia, Hector H.
    PATHOGENS AND GLOBAL HEALTH, 2012, 106 (05) : 305 - 309
  • [48] Anal cancer treatment: Current status and future perspectives
    Ghosn, Marwan
    Kourie, Hampig Raphael
    Abdayem, Pamela
    Antoun, Joelle
    Nasr, Dolly
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (08) : 2294 - 2302
  • [49] Nanomedicines for the treatment of glaucoma: Current status and future perspectives
    Zhai, Zimeng
    Cheng, Yiyun
    Hong, Jiaxu
    ACTA BIOMATERIALIA, 2021, 125 : 41 - 56
  • [50] Anal cancer treatment:Current status and future perspectives
    Marwan Ghosn
    Hampig Raphael Kourie
    Pamela Abdayem
    Joelle Antoun
    Dolly Nasr
    World Journal of Gastroenterology, 2015, (08) : 2294 - 2302